The global rat model market is projected to reach USD 588.9 Million by 2021 from 387.7 Million in 2016, growing at a CAGR of 8.7% during the forecast period.
Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth. However, increased benefits of cryopreservation and regulations & laws formulated for ethical use of animals in research are restraining the growth of the market to a certain extent.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; collaborations/agreement/partnerships/alliance, funding; licensing, contract, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.
- Charles River Laboratories International, Inc.
- Genoway S.A.
- Horizon Discovery Group PLC
- Janvier Labs
- Laboratory Corporation of America Holdings
- Taconic Biosciences, Inc.
- Transposagen Biopharmaceuticals, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Clinical Trials & Research Studies Assessment
7 Global Rat Model Market, By Model Type
8 Global Rat Model Market, By Service
9 Global Rat Model Market, By Technology
10 Global Rat Model Market, By Therapeutic Area
11 Global Rat Model Market, By End User
12 Global Rat Model Market, By Care Product
13 Global Rat Model Market, By Region
14 Competitive Landscape
15 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/kcz389/rat_model_market